Cost-effectiveness of sevelamer in the treatment of hyperphosphatemia associated with chronic kidney disease in Mexico

被引：0
|
作者：
Idrovo, J. [1 ]
Rivas, R. [1 ]
Zapata, L. [1 ]
机构：
[1] Guia Mark, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70949-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A301 / A301
页数：1
相关论文
共 50 条
  • [21] A SPANISH COST-EFFECTIVENESS ANALYSIS OF SEVELAMER VERSUS CALCIUM CARBONATE IN NONDIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (CKD) PATIENTS
    Subira, R.
    Rubio, M.
    Rodriguez-Carmona, A.
    Pons, R.
    del Pino, M. D.
    VALUE IN HEALTH, 2014, 17 (07) : A470 - A470
  • [22] Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients
    Hai V. Nguyen
    Saideep Bose
    Eric Finkelstein
    BMC Nephrology, 17
  • [23] A REVIEW OF COST-EFFECTIVENESS ANALYSES FOR ANEMIA IN CHRONIC KIDNEY DISEASE
    Lavelle, Tara
    Michalopoulos, Steven
    Margaretos, Nikki
    Berklein, Flora
    Shafai, Gigi
    Bozas, Ana
    Sanon, Myrlene
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 707 - 707
  • [24] Cost-Effectiveness Analysis of Screening Chronic Kidney Disease in Iran
    Ravaghi, Hamid
    Farzaneh, Ali
    Ebrahimnia, Mehdi
    Rostami, Zohreh
    Madani, Mohammad Hasan Hashemi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (11) : IC01 - IC04
  • [25] Cost-Effectiveness Analysis for the Treatment of Chronic Kidney Disease with Low-Protein Diet
    Mennini, F. S.
    Russo, S.
    Marcellusi, A.
    Palazzo, F.
    Quintaliani, P.
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2013, 3 (07): : 291 - +
  • [26] Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
    Goto, Shunsuke
    Komaba, Hirotaka
    Fukagawa, Masafumi
    Nishi, Shinichi
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (05) : 457 - 461
  • [27] Prevention and treatment of hyperphosphatemia in chronic kidney disease
    Vervloet, Marc G.
    van Ballegooijen, Adriana J.
    KIDNEY INTERNATIONAL, 2018, 93 (05) : 1060 - 1072
  • [28] Treatment of hyperphosphatemia with sevelamer in patients with chronic renal failure
    Suñer, M
    Guerrero, A
    Montes, R
    Rivera, A
    Ruiz, A
    Martínez-García, M
    Pérez-Valdivia, MA
    Mateos, J
    NEFROLOGIA, 2004, 24 (02): : 142 - 148
  • [29] COST-EFFECTIVENESS OF DORIPENEM IN THE TREATMENT OF VENTILATOR-ASSOCIATED PNEUMONIA IN MEXICO
    Soto-Molina, H.
    Celaya, J. M.
    Hernandez Guerrero, N.
    Castillejos, C.
    VALUE IN HEALTH, 2009, 12 (07) : A424 - A425
  • [30] The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease
    Brennan, Alan
    Akehurst, Ron
    Davis, Sarah
    Sakai, Hana
    Abbott, Victoria
    VALUE IN HEALTH, 2007, 10 (01) : 32 - 41
12345